DE69827017D1 - Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung - Google Patents

Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung

Info

Publication number
DE69827017D1
DE69827017D1 DE1998627017 DE69827017T DE69827017D1 DE 69827017 D1 DE69827017 D1 DE 69827017D1 DE 1998627017 DE1998627017 DE 1998627017 DE 69827017 T DE69827017 T DE 69827017T DE 69827017 D1 DE69827017 D1 DE 69827017D1
Authority
DE
Germany
Prior art keywords
endometrium
stage
estrogen
oral
atrophizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE1998627017
Other languages
English (en)
Other versions
DE69827017T2 (de
Inventor
Michael Kafrissen
Haya Taitel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of DE69827017D1 publication Critical patent/DE69827017D1/de
Application granted granted Critical
Publication of DE69827017T2 publication Critical patent/DE69827017T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE69827017T 1997-08-27 1998-08-20 Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung Expired - Lifetime DE69827017T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5710997P 1997-08-27 1997-08-27
US57109P 1997-08-27
PCT/US1998/017288 WO1999009993A1 (en) 1997-08-27 1998-08-20 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception

Publications (2)

Publication Number Publication Date
DE69827017D1 true DE69827017D1 (de) 2004-11-18
DE69827017T2 DE69827017T2 (de) 2006-03-09

Family

ID=22008560

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69827017T Expired - Lifetime DE69827017T2 (de) 1997-08-27 1998-08-20 Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung

Country Status (9)

Country Link
EP (1) EP1007052B1 (de)
JP (1) JP2001513566A (de)
AT (1) ATE279198T1 (de)
AU (1) AU9028098A (de)
DE (1) DE69827017T2 (de)
DK (1) DK1007052T3 (de)
ES (1) ES2230711T3 (de)
PT (1) PT1007052E (de)
WO (1) WO1999009993A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (fr) 1996-10-08 1998-12-24 Theramex Nouvelle composition hormononale et son utilisation
WO2001030355A1 (fr) 1999-10-25 2001-05-03 Laboratoire Theramex Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation
US7772219B2 (en) * 2003-05-02 2010-08-10 Teva Women's Health, Inc. Methods of hormonal treatment utilizing extended cycle contraceptive regimens
BRPI0412493A (pt) * 2003-07-16 2006-10-17 Duramed Pharmaceuticals Inc métodos de tratamento hormonal utilizando regimes contraceptivos com administração contìnua de estrogênio
EP1673094A1 (de) * 2003-10-01 2006-06-28 Janssen Pharmaceutica N.V. Erweiterte triphasische kontrazeptive schemata
EP1535618A1 (de) 2003-11-26 2005-06-01 Schering Aktiengesellschaft Pharmazeutische Zubereitung zur kontinuierlichen hormonellen Behandlung über einen Zeitraum von über 21-28 Tage beinhaltend zwei Estrogen und/oder Progestin Zusammensetzungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4616006A (en) * 1983-09-26 1986-10-07 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
IE61236B1 (en) * 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
ATE209919T1 (de) * 1987-09-24 2001-12-15 Jencap Res Ltd Oestrogen und progestin enthaltende verhütungspackungen
DE4104385C1 (de) * 1991-02-09 1992-08-13 Marika Dr.Med. 6509 Framersheim De Ehrlich

Also Published As

Publication number Publication date
JP2001513566A (ja) 2001-09-04
PT1007052E (pt) 2005-01-31
ES2230711T3 (es) 2005-05-01
EP1007052A1 (de) 2000-06-14
ATE279198T1 (de) 2004-10-15
WO1999009993A1 (en) 1999-03-04
EP1007052B1 (de) 2004-10-13
AU9028098A (en) 1999-03-16
DK1007052T3 (da) 2005-01-31
DE69827017T2 (de) 2006-03-09

Similar Documents

Publication Publication Date Title
NO964966D0 (no) Lactobacillusstammer av human opprinnelse, blandinger samt anvendelse derav
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
MX9203278A (es) Pastilla de liberacion sustentada que comprende loratadina, ibuprofen y pseudoefedrina.
IT8821134A0 (it) Frazioni oligomeriche procianidoliche, loro procedimentodi preparazione e composizioni farmaceutiche che le contengono.
ID28003A (id) Turunan-turunan adamantana
ID24520A (id) Analog-analog peptida lh-rh, penggunaannya dan komposisi farmasi yamg mengandungnya
DE59606094D1 (de) Hygienehose mit einem hosenelement und einem saugpolster
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
DE69932510D1 (de) Vaskularisierungsinhibitoren
NO20004419D0 (no) Ny anvendelse
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
ATE203519T1 (de) Chinolinderivate als antimalariamittel
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
NO995657D0 (no) Kombinasjonsterapi for endring av human seksuell respons
MX9302378A (es) Antagonistas de serotonina.
ES2140489T3 (es) Receptor de interferona soluble, su preparacion y su uso.
DK0680323T3 (da) Synergistisk kombination med antagonistvirkning ved NK1- og Nk2-receptorer.
DE69827017D1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
FR2718451B1 (fr) Dérivés de peptides boroniques, leur préparation et leur application en thérapeutique.
NO20001717D0 (no) Serotonin-inneholdende formulering for oral administrering og anvendelse av samme
DK0773782T3 (da) Terpenderivater (sarcodictyiner) anvendelse som antitumormidler
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
ES2152315T3 (es) Xamoneline tartrato.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN